UPDATE
: Friday, December 13, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Regulator OKs Jeil's advanced colorectal cancer treatment
by Lee Han-soo
2019-10-21 11:38
Ministry OKs ATGC's p1, 2 trial for BTX
by Lee Han-soo
2019-10-18 18:23
Physicians feel burdened by Ranitidine ban: survey
by Lee Han-soo
2019-10-18 16:48
Daewoong launches BTX in Canada
by Lee Han-soo
2019-10-18 14:31
CHA Biotech wins patent for somatic-cloned embryonic stem cell tech
by Lee Han-soo
2019-10-17 17:59
라인
US sales of Remicade drop due to biosimilar’s rise
by Jeong Sae-im
2019-10-17 13:32
'Eisai's Lenvima extends survival period, improves patients’ quality of life'
by Lee Han-soo
2019-10-16 18:22
‘New drug approval process takes about 300 days in Korea’
by Lee Han-soo
2019-10-16 15:06
Merck Korea forcefully shuts down general medicine biz
by Kim Yun-mi
2019-10-15 15:51
Galderma Korea’s key strategy: choice and concentration
by Kim Yun-mi
2019-10-15 13:56
라인
Medytox, Daewoong still in dispute over Nabota's spore appraisal
by Lee Han-soo
2019-10-15 11:28
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients
by Lee Han-soo
2019-10-14 18:01
HanAll's Chinese partner ends P2 trial of dry eye treatment
by Lee Han-soo
2019-10-14 14:08
[Special] How are Korean employees coping with big-pharma M&As?
by Kim Yun-mi
2019-10-14 13:45
Sanofi releases data showing improved survival for prostate cancer treatment
by Lee Han-soo
2019-10-14 12:16
라인
Regulator keeps Kolon Tissuegene listed with 1-year grace period
by Lee Han-soo
2019-10-12 09:41
GC to market Merck's diabetes treatment
by Lee Han-soo
2019-10-11 18:13
Bayer drugs out of stock in Korea
by Lee Han-soo
2019-10-11 16:36
Sanofi to cover part of Dupixent cost for atopic dermatitis patients
by Kim Yun-mi
2019-10-11 15:13
Takeda Korea’s labor union goes on strike
by Lee Han-soo
2019-10-11 14:33
-
1
2
3
4
5
6
7
8
9
10
다음
-
GC, Add Pharma to co-develop synthetic drugs
Helixmith to clarify why gene therapy study had data error
Daewoong releases trial results for autoimmune disease treatment candidate
Medical kiosks installed at major subway stations to help foreigners
GC, Add Pharma to co-develop synthetic drugs
Helixmith to clarify why gene therapy study had data error
Daewoong releases trial results for autoimmune disease treatment candidate
Medical kiosks installed at major subway stations to help foreigners
여백
Most viewed
1
Aprogen, 1st Korean biotech firm to win unicorn status
2
Korea selected as 'Medical Tourism Destination of the Year'
3
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
4
ABL Bio unveils new bispecific antibody at US meet
5
AbbVie's releases new data for chronic lymphocytic leukemia treatment
6
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
7
Samsung execs get jail term for destroying evidence
8
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
9
Korean physician 1st Asian to do 1,000 robotic myomectomy surgeries
10
Samsung Bioepis to start P3 trial for Ontruzant in China
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top